Diabetes for Professionals

Novo Nordisk Pharmaceuticals is pleased to offer this site to healthcare professionals with an interest in diabetes. D4Pro provides up-to-date medical information, news, a diabetes dictionary, an image bank, an events calendar and other resources to help you in your practice. Search the Abstract Database which includes over 8,000 diabetes-related abstracts from the past three years.

If you do not have flash installed please click here

Please feel free to contact us on webmaster@d4pro.com

Sitemap

Diabetic retinopathy: This section covers classification, screening and cases of diabetic retinopathy.
Diabetic retinopathy

Diabetic Neuropathy - foot: Information about feet and diabetes with sections covering infection, neuropathic ulcer, peripheral vascular disease, Charcot's arthropathy, and foot examination.
Diabetic neuropathy foot care

Childhood diabetes: This section covers Juvenile, Pediatric and Adolescent Diabetes. Guidelines (ISPAD 2000), Practical Reference Manual, Goals of Education.
Childhood Diabetes

Treatment Guidelines: Access to the recognized international Diabetes guidelines by American Diabetes Association (ADA) and International Diabetes Federation (IDF)
Diabetes Guidelines

Diabetes Research Editorials: A monthly newsletter reviewing a selection of the most important clinical abstracts published in major peer-reviewed journals in the previous month. Diabetes Monitor Alert is an abstract news supplement to the International Diabetes Monitor This website contains leading articles and clinical reviews of key publications in the current literature.
Diabetes research editorials

About Novo Nordisk

Novo Nordisk (Nova Nordisk, Nova Nordisc, Novo Nordisc) is a focused healthcare company.  With the broadest diabetes product portfolio in the industry, including the most advanced products within the area of insulin delivery systems, Novo Nordisk is the world leader in diabetes care.  In addition, Novo Nordisk has a leading position in areas such as haemostasis management, growth disorders and hormone replacement therapy.  Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society.